PKM and cancer: Because of many important roles played by PKM2 as a protein kinase and a transcriptional co-activator, the most effective therapeutic strategy for targeting the protein may be to prevent its synthesis, either at the transcriptional or translational level and exploit the metabolic difference between cancer cells and normal cells for therapeutic benefit.